Back to Search
JEFF MICHALSKI, MD
MD
Radiation Oncology Physician
NPI: 1902824410IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
R3K44(MO)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
MEDICAL COLLEGE OF WISCONSIN
Class of 1986
Research & Publications (20)
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.
PMID 19577865·Int J Radiat Oncol Biol Phys·2010
3-trial
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
PMID 19394158·Int J Radiat Oncol Biol Phys·2010
6-review
Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03.
PMID 19533025·J Neurooncol·2009
3-trial
ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
PMID 19386445·Int J Radiat Oncol Biol Phys·2009
6-review
Radiation therapy in the management of locally advanced prostate cancer.
PMID 16630525·Curr Urol Rep·2006
6-review
Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
PMID 15936549·Int J Radiat Oncol Biol Phys·2005
3-trial
Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
PMID 15234036·Int J Radiat Oncol Biol Phys·2004
8-other
Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
PMID 14967428·Int J Radiat Oncol Biol Phys·2004
3-trial
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.
PMID 12694838·Int J Radiat Oncol Biol Phys·2003
4-observational
Radiation exposure to family and household members after prostate brachytherapy.
PMID 12788183·Int J Radiat Oncol Biol Phys·2003
8-other
Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406.
PMID 11917289·Semin Radiat Oncol·2002
3-trial
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
PMID 10661346·Int J Radiat Oncol Biol Phys·2000
3-trial
Clinical trials and radiation oncology technologies.
PMID 19476270·Oncology (Williston Park)·2009
8-other
Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry.
PMID 19277556·Methods Mol Biol·2009
6-review
Mapping of O-linked beta-N-acetylglucosamine modification sites in key contractile proteins of rat skeletal muscle.
PMID 19322778·Proteomics·2009
7-preclinical
Phenylalanine 35 and tyrosine 82 are involved in the uptake and release of ligand by porcine odorant-binding protein.
PMID 19410020·Biochim Biophys Acta·2009
7-preclinical
Glycosylation pattern of brush border-associated glycoproteins in enterocyte-like cells: involvement of complex-type N-glycans in apical trafficking.
PMID 19426135·Biol Chem·2009
8-other
Phosphorylation of native porcine olfactory binding proteins.
PMID 19579044·J Chem Ecol·2009
7-preclinical
Quality control of glycoproteins bearing truncated glycans in an ALG9-defective (CDG-IL) patient.
PMID 19451548·Glycobiology·2009
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4921 PARKVIEW PL, SITEMAN CANCER CENTER LOWER LEVEL
SAINT LOUIS, MO 63110 - Phone
- (314) 747-7236
Quick Facts
- NPI
- 1902824410
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile